Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Addressing the Unique Challenges of Opioid Use Disorder in Women

Spilled bottle of pills

January 17, 2017 at 1:00 p.m. (ET)

Deaths from drug overdoses are the number one cause of injury death in the U.S. Most of these deaths are related to the misuse of prescription opioids and heroin. While men were more likely than women to die of opioid overdose, the number of overdose deaths from opioids among women has increased substantially. Since 1999, women’s deaths have quadrupled from prescription opioid overdose.

Consider the following:

  • Nearly 48,000 women died of prescription opioid overdose between 1999 and 2010.
  • For every woman who dies of a prescription opioid overdose, over 30 of them go the emergency department for opioid misuse or abuse.

Women’s biological differences may influence susceptibility to substance abuse, which could have implications for prevention and treatment. In order to identify and treat women most at risk, health care providers must be able to recognize and consider these differences.

Join us as we discuss how health care providers, researchers, and the public health community can best address the complexities of opioid use disorder among women. Speakers will give an overview of the federal response to the disorder, along with approaches to care and prevention of substance use.

Presentation

Beyond the Data – Addressing the Unique Challenges of Opioid Use Disorder in Women

Dr. John Iskander and Dr. Mishka Terplan, discuss how the opioid epidemic is impacting women differently than men. Tune in to hear how women’s gender and biological differences need to be considered when providing care and recommending policy on federal, state, and local levels.

Presented By:

Karin A. Mack, PhD
Associate Director for Science, Division of Analysis Research and Practice Integration, National Center for Injury Prevention and Control, CDC
“Overview of Opioid Use Disorder in Women and the Federal Response”

Linda Frazier, RN, MCHES, CADC
Director, Addictions Initiatives, Chair, APHA ATOD Section, Advocates for Human Potential, Inc.
“Comprehensive Approaches to Care of Women with Substance Use Disorders”

Mishka Terplan, MD, MPH, FACOG, FASAM
Professor, Department of Obstetrics and Gynecology, Professor, Department of Psychiatry, Associate Director, Addiction Medicine, Virginia Commonwealth University
“Prevention of Substance Use through Integration into Healthcare”

Facilitated By:

John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds
Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds

Continuing Education

This session is available for Continuing Education. Click here for more information.

  • Page last reviewed: December 30, 2016
  • Page last updated: December 30, 2016
  • Content source:
TOP